Semin Thromb Hemost 2000; Volume 26(Number 01): 023-028
DOI: 10.1055/s-2000-9798
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4663

Study of Cardiovascular Risk Factors and Hemostatic Molecular Markers in Elderly Persons

Katsumi Deguchi1 , Akira Deguchi2 , Hideo Wada3 , Seiko Murashima4
  • 1School of Nursing, Faculty of Medicine, Mie University, Tsu-city Mie-ken, Japan
  • 2Oyamada Memorial Spa Hospital, Tsu-city, Mie-ken, Japan
  • 32nd Department of Internal Medicine, Faculty of Medicine, Mie University, Tsu-city, Mie-ken, Japan
  • 4Mie Prefectural College of Nursing, Tsu-city Mie-ken, Japan
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 2000 (online)

 

ABSTRACT

In this study, plasma concentrations of hemostatic molecular markers were investigated in 118 elderly persons with normal renal function (aged 65 to 97 years) who could manage their activities of daily living (ADL) by themselves, to find a strategy for conservation or elevation of ADL and quality of life (QOL). In all subjects, the frequency by which hemostatic markers exceeded their upper limit of normal range was 35.9% for thrombin-antithrombin III complex (≥3.7 ng/ml), 38.3% for soluble fibrin monomer (≥4.0 μg/ml), 41.8% for D-dimer (≥1.0 μg/ml), 49.0% for plasmin-α2 plasmin inhibitor complex (≥1.0 μg/ml), and 53.7% for thrombomodulin (≥20 ng/ml). The mean plasma levels of these markers were slightly higher than the upper limit of their normal range. These markers were also investigated in samples of patients with and without cardiovascular risk factors and with and without cardiovascular diseases (ischemic heart disease and/or cerebral infarction). Furthermore, the results were analyzed in relationships between cardiovascular disease and cardiovascular risk factor or aging. The findings suggest that aging exerts a stronger influence on plasma levels of these hemostatic molecular markers than the presence of cardiovascular risk factors and cardiovascular diseases. From the viewpoint for conservation or elevation of ADL and QOL in elderly persons, also other factor, such as drug intake, lifestyle, aging, and so on, must be considered to clarify the relationship between the plasma levels of the hemostatic molecular markers and cardiovascular risk factors or cardiovascular diseases.

KEYWORD

Elderly - hemostatic molecular markers - cardiovascular risk factors - cardiovascular diseases

REFERENCES

  • 1 Kario K, Matsuo T, Kobayashi H. Which factors affect high D-dimer levels in the elderly?.  Thromb Res . 1991;  62 501-508
    CrossrefPubMedSuche in Google Scholar
  • 2 Deguchi A, Deguchi K, Shimura M. Spa bathing activates fibrinolysis in patients with cerebral infarction.  Intern Med . 1993;  32 619-622
    PubMedSuche in Google Scholar
  • 3 Deguchi A, Ohnishi K, Nakagawa H. Lipoprotein(a) and effective renal plasma flow rate in older patients with arteriosclerotic diseases.  JAGS . 1995;  43 1067-1068
    PubMedSuche in Google Scholar
  • 4 Deguchi K, Izumi K, Noguchi M, Wada H, Shirakawa S. Response of the cubital vein to occlusion and calcification of the abdominal aorta in patients with chronic renal failure on maintenance hemodialysis.  Thromb Res . 1988;  49 69-77
    CrossrefPubMedSuche in Google Scholar
  • 5 Deguchi K, Izumi K, Noguchi M. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.  Acta Haematol Jpn . 1989;  52 140-146
    PubMedSuche in Google Scholar
  • 6 Cushman M, Psaty B M, Macy E. Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease.  Arterioscler Thromb Vasc Biol . 1996;  16 1163-1169
    PubMedSuche in Google Scholar
  • 7 DeSouza C A, Jones P P, Seals D R. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.  Arterioscler Thromb Vasc Biol . 1998;  18 362-368
    PubMedSuche in Google Scholar
  • 8 Deguchi K, Noguchi M, Iwasaki E. Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT).  Am J Hematol . 1991;  38 86-89
    PubMedSuche in Google Scholar
  • 9 Deguchi K, Tsukada T, Oonishi K, Murashima S, Nishikawa M. Study on hyperactivated state of coagulation and fibrinolysis. In: Shen M-C, Teng C-M, Takada A, eds. Current Aspects of Blood Coagulation, Fibrinolysis and Platelets Tokyo: Springer-Verlag, 1993: 93-97
    Suche in Google Scholar
  • 10 Deguchi A, Ohnishi K, Nakamura S. Plasma thrombomodulin values and hepatorenal function in the elderly.  Arch Gerontol Geriatr . 1997;  24 47-54
    CrossrefPubMedSuche in Google Scholar
  • 11 Kapiotis S, Jilma B, Quehenberger P. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.  Circulation . 1997;  96 19-21
    PubMedSuche in Google Scholar
  • 12 Mari D, Mannucci P M, Coppola R. Hypercoagulability in centenarians: the paradox of successful aging.  Blood . 1995;  85 3144-3149
    PubMedSuche in Google Scholar
  • 13 Bijnen F CH, Feskens E JM, Giampaoli S. Haemostatic parameters and lifestyle factors in elderly men in Italy and The Netherlands.  Thromb Haemost . 1996;  76 411-416
    PubMedSuche in Google Scholar